Acquired heart disease in low-income and middle-income countries

被引:13
|
作者
Curry, Chris [1 ]
Zuhlke, Liesl [2 ]
Mocumbi, Ana [3 ]
Kennedy, Neil [1 ]
机构
[1] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Med Educ, Belfast BT12 6BA, Antrim, North Ireland
[2] Univ Cape Town, Cardiol, Cape Town, South Africa
[3] Univ Eduardo Mondlane, Cardiol, Maputo, Mozambique
关键词
ACUTE RHEUMATIC-FEVER; ENDOMYOCARDIAL FIBROSIS; CHILDREN; CARDIOMYOPATHY; EPIDEMIOLOGY; COMPLICATIONS; TUBERCULOSIS; POPULATION; PREVALENCE; OUTCOMES;
D O I
10.1136/archdischild-2016-312521
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The burden of illness associated with acquired cardiac disease in children in low-income and middle-income countries (LMIC) is significant and may be equivalent to that of congenital heart disease. Rheumatic heart disease, endomyocardial fibrosis, cardiomyopathy (including HIV cardiomyopathy) and tuberculosis are the most important causes. All are associated with poverty with the neediest children having the least access to care. The associated mortality and morbidity is high. There is an urgent need to improve cardiac care in LMIC, particularly in sub-Saharan Africa and parts of Southeast Asia where the burden is highest.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [41] Anal cancer screening in low-income and middle-income countries
    Blair, Kevin J.
    Liliana Valderrama-Beltran, Sandra
    Bautista-Arredondo, Sergio
    Juillard, Catherine
    Lombana Amaya, Luis Jorge
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (07): : 526 - 526
  • [42] Epilepsy stigma in children in low-income and middle-income countries
    Kariuki, Symon M.
    Thomas, Priya Treesa
    Newton, Charles R. J. C.
    LANCET CHILD & ADOLESCENT HEALTH, 2021, 5 (05): : 314 - 316
  • [43] Patient safety challenges in low-income and middle-income countries
    Steffner, Kirsten R.
    McQueen, K. A. Kelly
    Gelb, Adrian W.
    CURRENT OPINION IN ANESTHESIOLOGY, 2014, 27 (06) : 623 - 629
  • [44] Implications of technology guidelines for low-income and middle-income countries
    Tandon, Gupta Alpesh Goyal Nikhil
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (03): : 155 - 155
  • [45] Tackling antimicrobial resistance in low-income and middle-income countries
    Pokharel, Sunil
    Raut, Shristi
    Adhikari, Bipin
    BMJ GLOBAL HEALTH, 2019, 4 (06):
  • [46] Uncovering difference: a glimpse at patients with heart failure in low-income and middle-income countries
    Maggioni, Aldo P.
    LANCET GLOBAL HEALTH, 2017, 5 (07): : E634 - E635
  • [47] Heart failure in low-income and middle-income countries: failing REPORT card grades
    Naik, Nitish
    Narula, Jagat
    LANCET GLOBAL HEALTH, 2020, 8 (03): : E318 - E318
  • [48] Pathology and laboratory medicine in low-income and middle-income countries 2: Improving pathology and laboratory medicine in low-income and middle-income countries: roadmap to solutions
    Sayed, Shahin
    Cherniak, William
    Lawler, Mark
    Tan, Soo Yong
    El Sadr, Wafaa
    Wolf, Nicholas
    Silkensen, Shannon
    Brand, Nathan
    Looi, Lai Meng
    Pai, Sanjay A.
    Wilson, Michael L.
    Milner, Danny
    Flanigan, John
    Fleming, Kenneth A.
    LANCET, 2018, 391 (10133): : 1939 - 1952
  • [49] Chronic kidney disease in low-income to middle-income countries: the case for increased screening
    George, Cindy
    Mogueo, Amelie
    Okpechi, Ikechi
    Echouffo-Tcheugui, Justin B.
    Kengne, Andre Pascal
    BMJ GLOBAL HEALTH, 2017, 2 (02):
  • [50] Behavioral counseling for cardiovascular disease prevention in 36 low-income and middle-income countries
    Yan, Minghai
    Hu, Bo
    Tse, Lap Ah
    Zhu, Yingxuan
    Liu, Zhiguang
    Wang, Duolao
    Li, Wei
    PREVENTIVE MEDICINE, 2024, 185